PK
Prashant Kohli (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Grace Therapeutics, Inc. (GRCE). Across 1 priced purchase filing, the average 21-session return was -0.9% from execution and -8.9% from disclosure (delay-adjusted; derived). The largest single filing was $214K of GRCE (100,000 sh × $2.14, as filed), executed Sep 9. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-0.9%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-8.9%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$214K
shares × price, as filed
Last traded
Sep 9
Filed Sep 10
Median ADV $466K across their filed names
Open performance→Volume by month
Buys $214K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
GRCERecent filings
GRCEPURCHASE
Grace Therapeutics, Inc.
View filing →
$214K100,000 sh × $2.14
Exec Sep 9
Filed Sep 10 · 7:30 AM ET